Integrated Diagnostics Holdings plc (IDGXF)
USD 0.34
(0.0%)
USD 0.34
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 737.76 Million EGP | -37.02% |
| 2022 | 1.17 Billion EGP | -48.21% |
| 2021 | 2.26 Billion EGP | 129.52% |
| 2020 | 985.54 Million EGP | 24.62% |
| 2019 | 790.84 Million EGP | 15.46% |
| 2018 | 684.94 Million EGP | 26.75% |
| 2017 | 540.37 Million EGP | 15.91% |
| 2016 | 466.19 Million EGP | 74.3% |
| 2015 | 267.46 Million EGP | 9.13% |
| 2014 | 245.09 Million EGP | 84.09% |
| 2013 | 133.13 Million EGP | 102.22% |
| 2012 | 65.83 Million EGP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 220.22 Million EGP | 3.15% |
| 2024 Q2 | 214.71 Million EGP | -2.5% |
| 2023 Q3 | 288.08 Million EGP | 111.09% |
| 2023 Q4 | 213.48 Million EGP | -25.9% |
| 2023 FY | 737.76 Million EGP | -37.02% |
| 2023 Q1 | 261.57 Million EGP | -3.17% |
| 2023 Q2 | 136.47 Million EGP | -47.82% |
| 2022 Q2 | 166.06 Million EGP | -58.1% |
| 2022 Q1 | 396.36 Million EGP | -15.36% |
| 2022 Q4 | 270.13 Million EGP | 44.96% |
| 2022 Q3 | 186.36 Million EGP | 12.22% |
| 2022 FY | 1.17 Billion EGP | -48.21% |
| 2021 Q3 | 729.07 Million EGP | 38.35% |
| 2021 Q4 | 468.31 Million EGP | -35.77% |
| 2021 FY | 2.26 Billion EGP | 129.52% |
| 2021 Q2 | 526.99 Million EGP | -1.99% |
| 2021 Q1 | 537.68 Million EGP | 31.1% |
| 2020 Q4 | 410.14 Million EGP | 37.39% |
| 2020 FY | 985.54 Million EGP | 24.62% |
| 2020 Q3 | 298.53 Million EGP | 153.26% |
| 2020 Q2 | 117.87 Million EGP | -25.86% |
| 2020 Q1 | 158.99 Million EGP | -26.7% |
| 2019 Q2 | 167.48 Million EGP | -15.84% |
| 2019 Q1 | 199 Million EGP | 0.6% |
| 2019 FY | 790.84 Million EGP | 15.46% |
| 2019 Q4 | 216.91 Million EGP | 5.04% |
| 2019 Q3 | 206.51 Million EGP | 23.3% |
| 2018 FY | 684.94 Million EGP | 26.75% |
| 2018 Q2 | 146.69 Million EGP | 0.0% |
| 2018 Q4 | 197.8 Million EGP | 4.32% |
| 2018 Q1 | 146.69 Million EGP | -1.18% |
| 2018 Q3 | 189.61 Million EGP | 29.26% |
| 2017 Q2 | 112.12 Million EGP | 0.0% |
| 2017 FY | 540.37 Million EGP | 15.91% |
| 2017 Q1 | 112.12 Million EGP | 199.84% |
| 2017 Q3 | 167.75 Million EGP | 49.62% |
| 2017 Q4 | 148.44 Million EGP | -11.51% |
| 2016 Q2 | 112.01 Million EGP | 0.0% |
| 2016 FY | 466.19 Million EGP | 74.3% |
| 2016 Q4 | -112.29 Million EGP | -131.51% |
| 2016 Q3 | 356.37 Million EGP | 218.14% |
| 2016 Q1 | 112.01 Million EGP | 36.9% |
| 2015 Q2 | 105.18 Million EGP | 0.0% |
| 2015 Q1 | 105.18 Million EGP | 18.16% |
| 2015 FY | 267.46 Million EGP | 9.13% |
| 2015 Q4 | 81.82 Million EGP | 428.95% |
| 2015 Q3 | -24.87 Million EGP | -123.65% |
| 2014 Q4 | 89.01 Million EGP | 52.58% |
| 2014 Q3 | 58.34 Million EGP | -32.36% |
| 2014 Q2 | 86.24 Million EGP | -0.0% |
| 2014 Q1 | 86.24 Million EGP | 142.34% |
| 2014 FY | 245.09 Million EGP | 84.09% |
| 2013 FY | 133.13 Million EGP | 102.22% |
| 2013 Q2 | 33.21 Million EGP | 0.0% |
| 2013 Q3 | 33.21 Million EGP | 0.0% |
| 2013 Q4 | 35.58 Million EGP | 7.16% |
| 2013 Q1 | 33.21 Million EGP | 0.0% |
| 2012 FY | 65.83 Million EGP | 0.0% |
| 2012 Q4 | 33.21 Million EGP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | 59501.127% |
| Arrayit Corporation | -3.62 Million USD | 20466.0% |
| Atlantic International Corp. | -5.73 Million USD | 12969.792% |
| Biocept, Inc. | -31.98 Million USD | 2406.732% |
| Bioqual, Inc. | -19.63 Thousand USD | 3756908.229% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | 95647.451% |
| DermTech, Inc. | -103.73 Million USD | 811.171% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 70.335% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 3641.893% |
| iMD Companies, Inc. | -175.44 Thousand USD | 420606.595% |
| IDenta Corp. | -1499.00 USD | 49217044.63% |
| Interpace Biosciences, Inc. | 2.8 Million USD | -26211.056% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | -1906754.484% |
| InVitro International | -25.33 Thousand USD | 2911667.149% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 10458.916% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 1269651.9% |
| Medical Imaging Corp. | -819.48 Thousand USD | 90128.067% |
| NovelStem International Corp. | -3.52 Million USD | 21024.676% |
| Optigenex Inc. | 1.39 Million USD | -52944.538% |
| PharmChem, Inc. | 973.14 Thousand USD | -75711.979% |
| Proteome Sciences plc | -1.62 Million USD | 45612.77% |
| Response Genetics, Inc | -21.37 Million USD | 3551.195% |
| Rennova Health, Inc. | -1.4 Million USD | 52440.845% |
| RushNet, Inc. | -684.7 Thousand USD | 107848.885% |
| ScreenPro Security Inc. | -2.59 Million USD | 28558.341% |
| Stella Diagnostics Inc. | -11.42 Million USD | 6556.333% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 9623.49% |
| Todos Medical Ltd. | -9.74 Million USD | 7668.342% |